Cargando…
The Outcomes of Liver Transplantation in Severe Metabolic Dysfunction-Associated Steatotic Liver Disease Patients
The increasing prevalence of diabetes mellitus, obesity, and metabolic syndrome in the population can lead to metabolic dysfunction-associated steatohepatitis (MASH) and metabolic dysfunction-associated steatotic liver disease (MASLD). In Western industrialized countries, this has become a major pro...
Autores principales: | Paklar, Natasa, Mijic, Maja, Filipec-Kanizaj, Tajana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669065/ https://www.ncbi.nlm.nih.gov/pubmed/38002096 http://dx.doi.org/10.3390/biomedicines11113096 |
Ejemplares similares
-
Inflammatory bowel disease in liver transplanted patients
por: Filipec Kanizaj, Tajana, et al.
Publicado: (2017) -
Pretransplant Evaluation and Liver Transplantation Outcome in PBC Patients
por: Mijic, Maja, et al.
Publicado: (2022) -
Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2018) -
Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements
por: Mikolasevic, Ivana, et al.
Publicado: (2021) -
Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)